Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
Preclinical and clinical findings indicate that LEV has some anxiolytic potential. There is
reason to believe that compounds with anxiolytic activity may have broad clinical utility
across the anxiety spectrum. This trial was intended to explore LEV's utility in adults with
social anxiety disorder.